EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

Bin Cao, Yeming Wang, Hongzhou Lu, Chaolin Huang, Yumei Yang, Lianhan Shang, Zhu Chen, Rongmeng Jiang, Yihe Liu, Ling Lin, Ping Peng, Fuxiang Wang und 19 weitere

New England Journal of Medicine · 2024

DOI: 10.1056/nejmoa2301425 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Bin Cao und 30 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Pulmonary and Critical Care Medicine (B.C., Y.W., L.S., J.X., Chen Wang) and Clinical Research and Data Management (X.G.), In…. Hauptthemen laut MEDLINE: Coronavirus Protease Inhibitors, COVID-19. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronavirus Protease InhibitorsCOVID-19AdultHumansAdministration, OralAntiviral AgentsChinaCoronavirus M ProteinsCOVID-19 Drug TreatmentDouble-Blind MethodRitonavirSARS-CoV-2Time FactorsDrug Combinations

Substanzen

Antiviral AgentsCoronavirus M ProteinsCoronavirus Protease InhibitorsRitonavirDrug Combinations

Autor:innen und Institutionen

  • From the Departments of Pulmonary and Critical Care Medicine (B.C., Y.W., L.S., J.X., Chen Wang) and Clinical Research and Data Management (X.G.), Institute of Respiratory Medicine in the Chinese Academy of Medical Scie…

ORCID-Profile: Yinzhong Shen, Jiuyang Xu

Zitieren

APA

Cao, B., Wang, Y., Lu, H., Huang, C., Yang, Y., Shang, L., Chen, Z., Jiang, R., Liu, Y., Lin, L., Peng, P., Wang, F., Gong, F., Hu, H., Cheng, C., Yao, X., Ye, X., Zhou, H., Shen, Y., …, & Wang, C. (2024). Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2301425

Vancouver

Cao B, Wang Y, Lu H, Huang C, Yang Y, Shang L, et al. Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. New England Journal of Medicine. 2024. doi:10.1056/nejmoa2301425

BibTeX
@article{Cao2024,
  author = {Cao, Bin and Wang, Yeming and Lu, Hongzhou and Huang, Chaolin and Yang, Yumei and Shang, Lianhan and Chen, Zhu and Jiang, Rongmeng and Liu, Yihe and Lin, Ling and Peng, Ping and Wang, Fuxiang and Gong, Fengyun and Hu, Honglin and Cheng, Cong and Yao, Xiangyang and Ye, Xianwei and Zhou, Hourong and Shen, Yinzhong and Liu, Chenfan and Wang, Chunying and Yi, Zhennan and Hu, Bijie and Xu, Jiuyang and Gu, Xiaoying and Shen, Jingshan and Xu, Yechun and Zhang, Leike and Fan, Jia and Tang, Renhong and Wang, Chen},
  title = {Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejmoa2301425}
}
Kostenlos starten →